US 4,788,301 AGranted

Novel allylic amines

AssigneeMerrell Dow Pharmaceuticals Inc.

InventorsThomas M. Bargar, Robert Broersma, Jr., James R. McCarthy

Life of this patent

Estimating the term…

Abstract

This invention relates to novel .beta.-methylenethiophenethanamines which are mechanism-based inhibitors of dopamine beta-hydroxylase useful as antihypertensive agents.

Claims4

Dependent claims

A compound of the formula ##STR3## and the non-toxic pharmaceutically acceptable acid addition salts thereof.

Dependencies are inferred from the claim text.

Facts

Application: 07/062,813Filed 15 Jun 1987 · continuation
Priority: 31 Dec 1984
Granted: 29 Nov 1988
Term ends: Not estimatedThe source records don’t support an estimate.

Classification7 codes

C07D 409/06
Containing two hetero rings: linked by a carbon chain containing only aliphatic carbon atoms
A61P 9/12
Drugs for disorders of the cardiovascular system: antihypertensives
A61P 43/00
Drugs for specific purposes, not provided for in groups a61p1/00-a61p41/00
C07D 333/08
With only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms: hydrogen atoms or radicals…

Family

Serial687,628Parent of this continuation · filed 31 Dec 1984
Serial871,638Parent of this continuation · filed 6 Jun 1986
US 4,788,301 AThis patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…